Dopamine agonists and pathologic behaviors

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Kelley, Brendan J ^a   Duker, Andrew P ^a   Chiu, Peter ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PRAMIPEXOLE; ROPINIROLE;

BEHAVIOR DISORDER; CAUSAL ATTRIBUTION; DRUG WITHDRAWAL; HUMAN; HYPERSEXUALITY; LIMBIC CORTEX; NEUROANATOMY; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVIEW; REWARD; RISK ASSESSMENT; SUBSTANCE ABUSE;

EID: 84861085236     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/603631     Document Type: Review

References (52)

1. Ehringer H., Hornykiewicz O., Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system Klinische Wochenschrift 1960 38 1236 1239
2. Carlsson A., Lindqvist M., Magnusson T., 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists Nature 1957 180 4596 1200
3. Weill E., De lapomorphine dans certains troubles nerveux Lyon Med 1884 48 411 419
4. Schwab R. S., Amador L. V., Lettvin J. Y., Apomorphine in Parkinson's disease Transactions of the American Neurological Association 1951 56 251 253
5. Calne D. B., Teychenne P. F., Claveria L. E., Bromocriptine in Parkinsonism British Medical Journal 1974 4 5942 442 444
6. Voon V., Fernagut P. O., Wickens J., Baunez C., Rodriguez M., Pavon N., Juncos J. L., Obeso J. A., Bezard E., Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders The Lancet Neurology 2009 8 12 1140 1149
7. Lim S. Y., Evans A. H., Miyasaki J. M., Impulse control and related disorders in Parkinson's disease: review Annals of the New York Academy of Sciences 2008 1142 85 107
8. Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., Schwartz J. C., Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 1990 347 6289 146 151
9. Gerlach M., Double K., Arzberger T., Leblhuber F., Tatschner T., Riederer P., Dopamine receptor agonists in current clinical use: comparative dopamine rec (Pubitemid 37271855)
10. Perachon S., Schwartz J. C., Sokoloff P., Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors European Journal of Pharmacology 1999 366 2-3 293 300 (Pubitemid 29080794)
11. Piercey M. F., Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease Clinical Neuropharmacology 1998 21 3 141 151 (Pubitemid 28248773)
12. Gurevich E. V., Joyce J. N., Distribution of dopamine D3 receptor expressing neurons in the human forebrain comparison with D2 receptor expressing neurons Neuropsychopharmacology 1999 20 1 60 80 (Pubitemid 29010341)
13. Sokoloff P., Diaz J., Le Foll B., Guillin O., Leriche L., Bezard E., Gross C., The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders Current Drug Targets-CNS Neurological Disorders 2006 5 1 25 43 (Pubitemid 43796626)
14. Pilla M., Perachon S., Sautel F., Garrido F., Mann A., Wermuth C. G., Schwartz J. C., Everittt B. J., Sokoloff P., Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist Nature 1999 400 6742 371 375 (Pubitemid 29344203)
15. Acilli D., Fishburn C. S., Drago J., Steiner H., Lachowicz J. E., Park-B. H., Gauda E. B., Lee E. J., Cool M. H., Sibley D. R., Gerfen C. R., Westphal H., Fuchs S., A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice Proceedings of the National Academy of Sciences of the United States of America 1996 93 5 1945 1949 (Pubitemid 26079860)
16. Montastruc J. L., Schmitt L., Bagheri H., Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine Revue Neurologique 2003 159 4 441 443 (Pubitemid 36548165)
17. Guigoni C., Aubert I., Li Q., Gurevich V. V., Benovic J. L., Ferry S., Mach U., Stark H., Leriche L., Hkansson K., Bioulac B. H., Gross C. E., Sokoloff P., Fisone G., Gurevich E. V., Bloch B., Bezard E., Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors Parkinsonism and Related Disorders 2005 11 supplement 1 S25 S29
18. Visanji N. P., Fox S. H., Johnston T., Reyes G., Millan M. J., Brotchie J. M., Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease Neurobiology of Disease 2009 35 2 184 192
19. Gallagher D. A., O'Sullivan S. S., Evans A. H., Lees A. J., Schrag A., Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series Movement Disorders 2007 22 12 1757 1763 (Pubitemid 47597599)
20. Weintraub D., Koester J., Potenza M. N., Siderowf A. D., Stacy M., Voon V., Whetteckey J., Wunderlich G. R., Lang A. E., Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients Archives of Neurology 2010 67 5 589 595
21. Hassan A., Bower J. H., Kumar N., Matsumoto J. Y., Fealey R. D., Josephs K. A., Ahlskog J. E., Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies Parkinsonism and Related Disorders 2011 17 4 260 264
22. Bostwick J. M., Hecksel K. A., Stevens S. R., Bower J. H., Ahlskog J. E., Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease Mayo Clinic Proceedings 2009 84 4 310 316
23. D'Orsi G., Demaio V., Specchio L. M., Pathological gambling plus hypersexuality in restless legs syndrome: a new case Neurological Sciences 2011 32 4 707 709
24. Demetriades P., Rickards H., Cavanna A. E., Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects Parkinson's Disease 2011 2011 9
25. Broen M., Duits A., Visser-Vandewalle V., Temel Y., Winogrodzka A., Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review Parkinsonism and Related Disorders 2011 17 6 413 417
26. Ardouin C., Voon V., Worbe Y., Abouazar N., Czernecki V., Hosseini H., Pelissolo A., Moro E., Lhommée E., Lang A. E., Agid Y., Benabid A. L., Pollak P., Mallet L., Krack P., Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation Movement Disorders 2006 21 11 1941 1946 (Pubitemid 44848942)
27. Witjas T., Baunez C., Henry J. M., Delfini M., Regis J., Cherif A. A., Peragut J. C., Azulay J. P., Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation Movement Disorders 2005 20 8 1052 1055 (Pubitemid 41419526)
28. Bandini F., Primavera A., Pizzorno M., Cocito L., Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease Parkinsonism and Related Disorders 2007 13 6 369 371 (Pubitemid 47212785)
29. Knobel D., Aybek S., Pollo C., Vingerhoets F. J. G., Berney A., Rapid resolution of dopamine dysregulation syndrome (DDS) after subthalamic DBS for Parkinson disease (PD): a case report Cognitive and Behavioral Neurology 2008 21 3 187 189
30. Smeding H. M., Goudriaan A. E., Foncke E. M., Schuurman P. R., Speelman J. D., Schmand B., Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease Journal of Neurology, Neurosurgery and Psychiatry 2007 78 5 517 519 (Pubitemid 46662902)
31. Hlbig T. D., Tse W., Frisina P. G., Baker B. R., Hollander E., Shapiro H., Tagliati M., Koller W. C., Olanow C. W., Subthalamic deep brain stimulation and impulse control in Parkinson's disease European Journal of Neurology 2009 16 4 493 497
32. Lim S. Y., O'Sullivan S. S., Kotschet K., Gallagher D. A., Lacey C., Lawrence A. D., Lees A. J., O'Sullivan D. J., Peppard R. F., Rodrigues J. P., Schrag A., Silberstein P., Tisch S., Evans A. H., Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease Journal of Clinical Neuroscience 2009 16 9 1148 1152
33. Frank M. J., Hold your horses: a dynamic computational role for the subthalamic nucleus in decision making Neural Networks 2006 19 8 1120 1136 (Pubitemid 44466333)
34. Frank M. J., Samanta J., Moustafa A. A., Sherman S. J., Hold your horses: impulsivity, deep brain stimulation, and medication in Parkinsonism Science 2007 318 5854 1309 1312 (Pubitemid 350172897)
35. Mamikonyan E., Siderowf A. D., Duda J. E., Potenza M. N., Horn S., Stern M. B., Weintraub D., Long-term follow-up of impulse control disorders in Parkinson's disease Movement Disorders 2008 23 1 75 80 (Pubitemid 351281221)
36. Bharmal A., Lu C., Quickfall J., Crockford D., Suchowersky O., Outcomes of patients with Parkinson disease and pathological gambling The Canadian Journal of Neurological Sciences 2010 37 4 473 477
37. Dodd M. L., Klos K. J., Bower J. H., Geda Y. E., Josephs K. A., Ahlskog J. E., Pathological gambling caused by drugs used to treat Parkinson disease Archives of Neurology 2005 62 9 1377 1381 (Pubitemid 41352054)
38. Voon V., Gao J., Brezing C., Symmonds M., Ekanayake V., Fernandez H., Dolan R. J., Hallett M., Dopamine agonists and risk: impulse control disorders in Parkinson's; disease Brain 2011 134 5 1438 1446
39. Reuter J., Raedler T., Rose M., Hand I., Glscher J., Bchel C., Pathological gambling is linked to reduced activation of the mesolimbic reward system Nature Neuroscience 2005 8 2 147 148 (Pubitemid 40194043)
40. Rao H., Korczykowski M., Pluta J., Hoang A., Detre J. A., Neural correlates of voluntary and involuntary risk taking in the human brain: an fMRI study of the balloon analog risk task (BART) NeuroImage 2008 42 2 902 910
41. Steeves T. D., Miyasaki J., Zurowski M., Lang A. E., Pellecchia G., Van Eimeren T., Rusjan P., Houle S., Strafella A. P., Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study Brain 2009 132 5 1376 1385
42. Van Eimeren T., Pellecchia G., Cilia R., Ballanger B., Steeves T. D. L., Houle S., Miyasaki J. M., Zurowski M., Lang A. E., Strafella A. P., Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD Neurology 2010 75 19 1711 1716
43. Kahnemann D., Tversky A., Kahnemann D., Tversky A., Prospect theory: an analysis of decision under risk Choices, Values and Frames 2000 New York, NY, USA Cambridge University Press
44. Kapogiannis D., Mooshagian E., Campion P., Grafman J., Zimmermann T. J., Ladt K. C., Wassermann E. M., Reward processing abnormalities in Parkinson's disease Movement Disorders 2011 26 8 1451 1457
45. Bloch M. H., Peterson B. S., Scahill L., Otka J., Katsovich L., Zhang H., Leckman J. F., Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome Archives of Pediatrics and Adolescent Medicine 2006 160 1 65 69 (Pubitemid 43042137)
46. Steeves T. D., Ko J. H., Kideckel D. M., Rusjan P., Houle S., Sandor P., Lang A. E., Strafella A. P., Extrastriatal dopaminergic dysfunction in Tourette syndrome Annals of Neurology 2010 67 2 170 181
47. De Carolis L., Schepisi C., Milella M. S., Nencini P., Clomipramine, but not haloperidol or aripiprazole, inhibits quinpirole-induced water contrafreeloading, a putative animal model of compulsive behavior Psychopharmacology 2011 218 4 749 759
48. Kontis D., Boulougouris V., Papakosta V. M., Kalogerakou S., Papadopoulos S., Poulopoulou C., Papadimitriou G. N., Tsaltas E., Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder Psychopharmacology 2008 200 4 597 610
49. Achat-Mendes C., Grundt P., Cao J., Platt D. M., Newman A. H., Spealman R. D., Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys Journal of Pharmacology and Experimental Therapeutics 2010 334 2 556 565
50. Thiel K. J., Wenzel J. M., Pentkowski N. S., Hobbs R. J., Alleweireldt A. T., Neisewander J. L., Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior Behavioural Brain Research 2010 214 2 386 394
51. Bordet R., Ridray S., Carboni S., Diaz J., Sokoloff P., Schwartz J. C., Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa Proceedings of the National Academy of Sciences of the United States of America 1997 94 7 3363 3367 (Pubitemid 27157317)
52. Bézard E., Ferry S., Mach U., Stark H., Leriche L., Boraud T., Gross C., Sokoloff P., Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function Nature Medicine 2003 9 6 762 767 (Pubitemid 36749227)